AstraZeneca has brought in Iskra Reic to replace Leon Wang, who is on extended leave from the Anglo-Swedish drugmaker while ...

US drugmaker Eli Lilly enjoyed a good day on the obesity front on Wednesday, with the news that its GLP-1 receptor agonist tirzepatide - branded as Wegovy and Mounjaro - outscored its main rival from ...

Privately-held Dewpoint Therapeutics, a Boston, USA, biotech developing therapeutics by targeting biomolecular condensates, ...

Refoxy Pharmaceuticals secures €9.1 million in seed-extension funding led by Boehringer Ingelheim Venture Fund to advance its ...

Massachusetts, USA-based clinical stage biotech Rgenta Therapeutics, which is developing a new class of oral small molecules ...

Shares of US precision medicines firm Relay Therapeutics closed down 6% at $4.39 yesterday after announced a licensing deal ...

UK’s MHRA is called to restore its reputation post-Brexit by the ABPI, emphasizing the need for more resources and flexible ...

Cartesian Therapeutics reports positive Phase IIb results for Descartes-08 in generalized myasthenia gravis, achieving ...

Chinese biotech Duality Biologics yesterday revealed that it has entered into an exclusive option agreement with UK pharma ...

Boston-based AI Proteins, a biotech that uses computational de novo protein design to create therapeutic miniproteins, has ...

The battle between the two front runners in the vast weight loss released top-line results from the SURMOUNT-5 Phase IIIb ...

Brexit by the ABPI, emphasizing the need for more resources and flexible licensing. The regulator faces challenges including ...